Skip to main navigation Skip to search Skip to main content

Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

  • Ajay K. Gopal
  • , Brad S. Kahl
  • , Christopher R. Flowers
  • , Peter Martin
  • , Stephen M. Ansell
  • , Esteban Abella-Dominicis
  • , Brian Koh
  • , Wei Ye
  • , Paul M. Barr
  • , Gilles A. Salles
  • , Jonathan W. Friedberg

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)3037-3039
Number of pages3
JournalBlood
Volume129
Issue number22
DOIs
StatePublished - Jun 1 2017

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this